Graves DT - Search Results

1

Targeting the succinate receptor effectively inhibits periodontitis.

Guo Y, Xu F, Thomas SC, Zhang Y, Paul B, Sakilam S, Chae S, Li P, Almeter C, Kamer AR, Arora P, Graves DT, Saxena D, Li X. Guo Y, et al. Among authors: graves dt. Cell Rep. 2022 Sep 20;40(12):111389. doi: 10.1016/j.celrep.2022.111389. Cell Rep. 2022. PMID: 36130514 Free PMC article.

2

The enduring importance of animal models in understanding periodontal disease.

Hajishengallis G, Lamont RJ, Graves DT. Hajishengallis G, et al. Among authors: graves dt. Virulence. 2015;6(3):229-35. doi: 10.4161/21505594.2014.990806. Virulence. 2015. PMID: 25574929 Free PMC article. Review.

3

Osteoblast Lineage Cells Play an Essential Role in Periodontal Bone Loss Through Activation of Nuclear Factor-Kappa B.

Pacios S, Xiao W, Mattos M, Lim J, Tarapore RS, Alsadun S, Yu B, Wang CY, Graves DT. Pacios S, et al. Among authors: graves dt. Sci Rep. 2015 Dec 15;5:16694. doi: 10.1038/srep16694. Sci Rep. 2015. PMID: 26666569 Free PMC article.

4

Diabetes Enhances IL-17 Expression and Alters the Oral Microbiome to Increase Its Pathogenicity.

Xiao E, Mattos M, Vieira GHA, Chen S, Corrêa JD, Wu Y, Albiero ML, Bittinger K, Graves DT. Xiao E, et al. Among authors: graves dt. Cell Host Microbe. 2017 Jul 12;22(1):120-128.e4. doi: 10.1016/j.chom.2017.06.014. Cell Host Microbe. 2017. PMID: 28704648 Free PMC article.

5

The Interrelationship Between Diabetes, IL-17 and Bone Loss.

Huang Z, Pei X, Graves DT. Huang Z, et al. Among authors: graves dt. Curr Osteoporos Rep. 2020 Feb;18(1):23-31. doi: 10.1007/s11914-020-00559-6. Curr Osteoporos Rep. 2020. PMID: 32002770 Free PMC article. Review.

6

Osteoimmunology in Periodontitis and Orthodontic Tooth Movement.

Alghamdi B, Jeon HH, Ni J, Qiu D, Liu A, Hong JJ, Ali M, Wang A, Troka M, Graves DT. Alghamdi B, et al. Among authors: graves dt. Curr Osteoporos Rep. 2023 Apr;21(2):128-146. doi: 10.1007/s11914-023-00774-x. Epub 2023 Mar 2. Curr Osteoporos Rep. 2023. PMID: 36862360 Free PMC article. Review.

7

Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis.

Graves DT, Delima AJ, Assuma R, Amar S, Oates T, Cochran D. Graves DT, et al. J Periodontol. 1998 Dec;69(12):1419-25. doi: 10.1902/jop.1998.69.12.1419. J Periodontol. 1998. PMID: 9926773

8

Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis.

Delima AJ, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S, Graves DT. Delima AJ, et al. Among authors: graves dt. J Clin Periodontol. 2001 Mar;28(3):233-40. doi: 10.1034/j.1600-051x.2001.028003233.x. J Clin Periodontol. 2001. PMID: 11284536

9

Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists.

Delima AJ, Karatzas S, Amar S, Graves DT. Delima AJ, et al. Among authors: graves dt. J Infect Dis. 2002 Aug 15;186(4):511-6. doi: 10.1086/341778. Epub 2002 Jul 24. J Infect Dis. 2002. PMID: 12195378

10

Evidence that diabetes mellitus aggravates periodontal diseases and modifies the response to an oral pathogen in animal models.

Graves DT, Al-Mashat H, Liu R. Graves DT, et al. Compend Contin Educ Dent. 2004 Jul;25(7 Suppl 1):38-45. Compend Contin Educ Dent. 2004. PMID: 15645885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page